首页> 外文期刊>Journal of receptor and signal transduction research >Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases
【24h】

Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases

机译:过氧化物酶体增殖物激活受体/视黄酸受体与肾脏疾病的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Peroxisome proliferator-activated receptor-γ (PPARγ), belongs to the nuclear receptor superfamily, and is a nuclear transcription receptor involving in the regulation of several biochemical pathways, such as cell growth, differentiation, and apoptosis. The nuclear retinoic acid receptors (RARs) are transcriptional transregulators that control the expression of specific subsets of genes in a ligand-dependent manner, and include three subtypes (RARα, RARβ, and RARγ). These control the expression of specific gene subsets subsequent to ligand binding and to strictly control phosphorylation processes. The current status of knowledge indicates that there might be inter- or overlapping actions between PPARγ and RARs, and there might be an association of PPARγ/RARs with renal diseases. Various agonists of both receptor families seem to prevent or retard the progression of renal disease. Herein, we review if causal relationships can be established between PPARγ/RARs and renal diseases and its manifestations.
机译:过氧化物酶体增殖物激活受体-γ(PPARγ),属于核受体超家族,是一种核转录受体,参与多种生化途径的调控,例如细胞生长,分化和凋亡。核视黄酸受体(RARs)是转录转调节子,以配体依赖性方式控制基因特定子集的表达,并包括三种亚型(RARα,RARβ和RARγ)。这些在配体结合之后控制特定基因子集的表达,并严格控制磷酸化过程。当前的知识状态表明,PPARγ和RAR之间可能存在相互作用或重叠作用,并且PPARγ/ RAR与肾脏疾病之间可能存在关联。两个受体家族的各种激动剂似乎预防或延缓了肾脏疾病的进展。在本文中,我们回顾了是否可以在PPARγ/ RAR与肾脏疾病及其表现之间建立因果关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号